about
Fortifying the Treatment of Prostate Cancer with Physical ActivityWeight gain, metabolic syndrome, and breast cancer recurrence: are dietary recommendations supported by the data?Anti-Tumor Effects of Ketogenic Diets in Mice: A Meta-Analysis.Radiation therapy for locally recurrent breast cancer.Fractionated stereotactic radiation therapy improves cranial neuropathies in patients with skull base meningiomas: a retrospective cohort study.Calories, carbohydrates, and cancer therapy with radiation: exploiting the five R's through dietary manipulation.Postprostatectomy radiation therapy: an evidence-based review.Stereotactic radiotherapy for trigeminal schwannomas.Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme.Conditional survival probabilities for patients with resected pancreatic adenocarcinoma.Patterns of care for elderly men diagnosed with favorable-risk prostate cancer from 2004 to 2008: a population-based analysis.Re-resection for recurrent high-grade glioma in the setting of re-irradiation: more is not always better.Evaluating changes in radiation treatment volumes from post-operative to same-day planning MRI in High-grade gliomas.Primary pancreatic lymphoma: a population-based analysis using the SEER program.RT-26RE-RESECTION FOR RECURRENT HIGH GRADE GLIOMA IN THE SETTING OF RE-IRRADIATION: SURVIVAL OUTCOMES UPDATE.RT-31SURVIVAL OUTCOMES IN PATIENTS RECEIVING BOTH FRACTIONATED STEREOTACTIC RADIOTHERAPY AND BEVACIZUMAB FOR RECURRENT HIGH GRADE GLIOMA.Reduced-dose fractionated stereotactic radiotherapy for acoustic neuromas: maintenance of tumor control with improved hearing preservation.Optimizing patient positioning for intensity modulated radiation therapy in hippocampal-sparing whole brain radiation therapy.Assessing Changes in the Activity Levels of Breast Cancer Patients During Radiation Therapy.Standardization of nodal radiation therapy through changes to a breast cancer clinical pathway throughout a large, integrated cancer center network.Corticosteroids compromise survival in glioblastoma in part through their elevation of blood glucose levels.Commentary on "Strong adverse prognostic impact of hyperglycemic episodes during adjuvant chemoradiotherapy of glioblastoma multiforme".Meat, eggs, full-fat dairy, and nutritional boogeymen: Does the way in which animals are raised affect health differently in humans?Targeting Tumor Metabolism With Statins During Treatment for Advanced-stage Pancreatic Cancer.Need for new review of article on ketogenic dietary regimes for cancer patients.Images in clinical medicine. Radiation recall and woody fibrosis.Application of Bayesian evidence synthesis to modelling the effect of ketogenic therapy on survival of high grade glioma patientsTracking steps in oncology: the time is nowData of unhealthy food availability in hospitalsMaximizing Polyphenol Content to Uncork the Relationship Between Wine and CancerThe Impact of Serum Glucose, Anti-Diabetic Agents, and Statin Usage in Non-small Cell Lung Cancer Patients Treated With Definitive Chemoradiation.Is completion axillary lymph node dissection necessary in patients who are underrepresented in the ACOSOG Z0011 trial?Determination of internal target volume using selective phases of a 4-dimensional computed tomography scanHospitals lead by poor example: An assessment of snacks, soda, and junk food availability in Veterans Affairs hospitalsHypofractionated Whole-Breast Irradiation in Large-Breasted Women-Is There a Dosimetric Predictor for Acute Skin Toxicities?Bevacizumab and re-irradiation for recurrent high grade gliomas: does sequence matter?Physician Burnout and Physician Health: Three Simple Suggestions for a Complex ProblemIs Multifocal Regression a Risk Factor for Ipsilateral Breast Tumor Recurrence in the Modern Era After Neoadjuvant Chemotherapy and Breast Conservation Therapy?Assessment of deep inspiration breath hold technique setup reproducibility using mega voltage imaging for left breast cancer radiation therapy-integrated network studyIn reply
P50
Q26765503-DD9F04CE-C1F5-4443-B885-C118770107C0Q30572730-07A588FE-67EF-4A5D-A6F0-CDDE1025A119Q36012197-9D88FFC7-FD1C-4FBA-B73C-A05E47B7F881Q36317919-BE35B5C0-25A1-482B-88ED-B4BA15221BE2Q36552448-986061E6-AD9C-4050-AA3D-824F2107F9C7Q37705691-9844A9F3-E70A-4472-83E8-A80FAE353CF6Q37960204-CB777284-3EB4-4140-B977-6DB5E79CCBBCQ37999603-09B04032-DACF-41BB-9998-67E237365049Q38179992-15A86CE0-04DE-4F9A-BCDB-5FBC5DAA6873Q39528120-EDBF5A3E-24B8-485F-AFBC-E5196BAB2D6EQ39569365-F3EBEE87-EDF3-47FE-B6FC-F06054057963Q40889745-03591A48-42E3-47A9-B00E-16EC994DEBE5Q42173052-36E87078-4B82-4A6C-9936-FCF692EA38B5Q44145828-2E485A91-34A1-492F-894B-045466FE881BQ45795206-0169289D-8088-4FC0-B886-72188117C643Q45891853-CD5BFE66-B7BC-4899-A6CB-7DDF8CE20801Q45892521-86954BFF-85D5-4491-8DCA-75C59E3C8359Q46945956-2654F406-A226-47FE-846B-816CE9E60200Q47669144-B65BB300-D347-4A3B-84BA-5FCF46F4B41DQ47933984-0A2E4FDE-C002-4B64-BA4E-109A547DEF5FQ48385511-E96C5548-4D37-4D7B-8E18-A7F07FD1B936Q48419791-A5610F92-ACE9-426D-AE4F-E3800327C713Q52578183-A4B1A473-8D6A-41AB-BC9A-CC0ADF113260Q53273637-5FC88E05-AA4B-48D2-9B2F-3D51743405EEQ53326526-2534C5FA-8631-47D0-A2E4-D8D4A1652AA0Q53509259-746B9FD6-5F69-4EF2-BB6E-4BD542CA2877Q58765731-004A0184-483C-4A1E-AE18-B6DB06F54CC6Q58802198-0F2796FE-5490-4A36-B2E8-9E5D89FEAF68Q59807200-C6286A8E-0378-4279-AACE-CEEE418B4596Q64078963-F4EA4B07-D8F0-47D2-AC4D-434E1F22C4DEQ64972488-BC5D3B65-B867-4976-836B-42AC71766B3AQ64977420-0AEFF3B9-A553-4CD8-B101-BD7BA9620B3CQ87534206-C80EFDD3-01E6-4E5B-AF46-77B551FE3693Q90360501-82297DFF-4CE5-4049-8006-827135A66951Q91141710-E6BC52E7-E59F-4CE8-BE9A-697B97B0DF2CQ91291333-D2302362-4A09-40BE-BC6E-8F37C89C1664Q91942797-A81E48D1-5206-4D87-BA84-2055C2EEC386Q92457695-92400760-68D1-42AF-A1F4-D3FD196FE6C2Q92462136-5BC1A82D-74D5-4C7E-B18C-552C786FDFEEQ93590521-2CFD3B84-E53E-4FE2-A914-961371EA4D25
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Colin E Champ
@ast
Colin E Champ
@en
Colin E Champ
@es
Colin E Champ
@nl
Colin E Champ
@sl
type
label
Colin E Champ
@ast
Colin E Champ
@en
Colin E Champ
@es
Colin E Champ
@nl
Colin E Champ
@sl
prefLabel
Colin E Champ
@ast
Colin E Champ
@en
Colin E Champ
@es
Colin E Champ
@nl
Colin E Champ
@sl
P106
P21
P31
P496
0000-0002-1879-7463